ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 036,72
-0,07%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Galera Therapeutics Inc (GRTX)

  7. Galera Therapeutics Inc (GRTX) Actualités

GRTX

Galera Therapeutics (GRTX)

Galera Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GRTX
DateHeureSourceTitreSymboleSociété
16/05/202416h26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
16/05/202416h26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
16/05/202416h25Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GRTXGalera Therapeutics Inc
13/05/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRTXGalera Therapeutics Inc
13/05/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRTXGalera Therapeutics Inc
13/05/202413h00GlobeNewswire Inc.Galera Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
03/05/202413h00GlobeNewswire Inc.Galera Adopts Limited Duration Stockholder Rights AgreementNASDAQ:GRTXGalera Therapeutics Inc
28/03/202412h00GlobeNewswire Inc.Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
26/02/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRTXGalera Therapeutics Inc
21/02/202400h57Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:GRTXGalera Therapeutics Inc
14/11/202313h00GlobeNewswire Inc.Galera Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
31/10/202313h09Dow Jones NewsGalera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3 TrialNASDAQ:GRTXGalera Therapeutics Inc
31/10/202312h00GlobeNewswire Inc.Galera Announces Receipt of Type A Meeting Minutes and Strategic UpdateNASDAQ:GRTXGalera Therapeutics Inc
18/09/202313h00GlobeNewswire Inc.Galera Schedules Type A Meeting with FDA to Discuss Next Steps for AvasopasemNASDAQ:GRTXGalera Therapeutics Inc
05/09/202313h00GlobeNewswire Inc.Galera to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:GRTXGalera Therapeutics Inc
14/08/202313h00GlobeNewswire Inc.Galera Reports Second Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
10/08/202302h10Dow Jones NewsStocks to Watch: Applovin, Disney, Galera TherapeuticsNASDAQ:GRTXGalera Therapeutics Inc
09/08/202323h23Dow Jones NewsGalera Therapeutics to Reduce Workforce by 70% to Extend Cash RunwayNASDAQ:GRTXGalera Therapeutics Inc
09/08/202322h31GlobeNewswire Inc.Galera Receives Complete Response Letter from U.S. FDA for Avasopasem ManganeseNASDAQ:GRTXGalera Therapeutics Inc
28/06/202322h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRTXGalera Therapeutics Inc
16/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GRTXGalera Therapeutics Inc
05/06/202320h15GlobeNewswire Inc.Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual MeetingNASDAQ:GRTXGalera Therapeutics Inc
18/05/202314h44Dow Jones NewsGalera Therapeutics Gets Orphan Drug Designation for RucosopasemNASDAQ:GRTXGalera Therapeutics Inc
18/05/202314h00GlobeNewswire Inc.Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic CancerNASDAQ:GRTXGalera Therapeutics Inc
11/05/202322h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRTXGalera Therapeutics Inc
11/05/202313h00GlobeNewswire Inc.Galera Reports First Quarter 2023 Financial Results and Recent Corporate UpdatesNASDAQ:GRTXGalera Therapeutics Inc
04/05/202322h01GlobeNewswire Inc.Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GRTXGalera Therapeutics Inc
01/05/202313h00GlobeNewswire Inc.Galera Expands Commercial Leadership TeamNASDAQ:GRTXGalera Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GRTX

Dernières Valeurs Consultées

KUCN
XPRUSDT
Proton
NASDAQ
NLIT
Northern Lights Acquisit...
BIT
UB4QCT
Unicredit Bank
USOTC
BMKDF
Biomark Diagnostics (PK)
COIN
CALIUST
CaliCoin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés